Market cap
$99.8B
Price as of
2026-10-29
Latest filing
8-K
Alerts
8
Price$85.50 +3.72% 3M daily closessample
86.2679.72
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 20INS
- Oct 09INS
- Oct 01INS
- Sep 28INS
- Sep 21INS
- Sep 11INS
- Sep 04INS
- Aug 27INS
Company facts
SEC EDGAR registration- Name
- NYMOX PHARMACEUTICAL CORP
- Sector
- Healthcare
- Industry
- Biotechnology
- Smart-money score
- -18sample, -100 to +100
- Reporting currency
- USD
Who is positioning in NYMXF
sample- Insiders
- 33 insider transactions over 90 days, net selling, $837.3M
- Congress
- 2 members traded over 90 days
- Institutions · 13F
- 7 funds hold $754.8M
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$5.6B +18.4% y/y
Q4 2024Q3 2026
Inventory$3.4B +21.7% y/y
Q4 2024Q3 2026
Accounts receivable$2.4B +8.5% y/y
Q4 2024Q3 2026
Total debt$6.3B +6.8% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $52.8B -0.8% 3M
- Sample peer B
- $65.2B +0.5% 3M
- Sample peer C
- $22.4B +16.5% 3M
- Sample peer D
- $37.8B +2.8% 3M
- Sample peer E
- $57.9B +7.4% 3M